The Brazilian Consensus For The Clinical Approach And Treatment Of Subclinical Hypothyroidism In Adults: Recommendations Of The Thyroid Department Of The Brazilian Society Of Endocrinology And Metabolism [consenso Brasileiro Para A Abordagem Clínica E Tratamento Do Hipotireoidismo Subclínico Em Adultos: Recomendações Do Departamento De Tireoide Da Sociedade Brasileira De Endocrinologia E Metabologia]

Introduction: Subclinical hypothyroidism (SCH), defined as elevated concentrations of thyroid stimulating hormone (TSH) despite normal levels of thyroid hormones, is highly prevalent in Brazil, especially among women and the elderly. Although an increasing number of studies have related SCH to an increased risk of coronary artery disease and mortality, there have been no randomized clinical trials verifying the benefit of levothyroxine treatment in reducing these risks, and the treatment remains controversial. Objective: This consensus, sponsored by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism and developed by Brazilian experts with extensive clinical experience with thyroid diseases, presents these recommendations based on evidence for the clinical management of SCH patients in Brazil. Materials and methods: After structuring the clinical questions, the search for evidence in the literature was initially performed in the MedLine-PubMed database and later in the Embase and SciELO - Lilacs databases. The strength of evidence was evaluated according to the Oxford classification system and established based on the experimental design used, considering the best available evidence for each question and the Brazilian experience. Results: The topics covered included SCH definition and diagnosis, natural history, clinical significance, treatment and pregnancy, and the consensus issued 29 recommendations for the clinical management of adult patients with SCH. Conclusion: Treatment with levothyroxine was recommended for all patients with persistent SCH with serum TSH values ≥ 10 mU/L and for certain patient subgroups.573166183Surks, M.I., Ortiz, E., Daniels, G.H., Sawin, C.T., Col, N.F., Cobin, R.H., Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management (2004) JAMA., 291, pp. 228-238Cooper, D.S., Biondi, B., Subclinical thyroid disease (2012) Lancet., 379, pp. 1142-1154Romaldini, J.H., Sgarbi, J.A., Farah, C.S., Subclinical thyroid disease: Subclinical hypothyroidism and hyperthyroidism (2004) Arq Bras Endocrinol Metab., 48, pp. 147-158Hollowell, J.G., Staehling, N.W., Flanders, W.D., Hannon, W.H., Gunter, E.W., Spencer, C.A., Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) (2002) J Clin Endocrinol Metab., 87, pp. 489-499Canaris, G.J., Manowitz, N.R., Mayor, G., Ridgway, E.C., The Colorado Thyroid Disease Prevalence Study (2000) Arch Int Med., 160, pp. 526-534Parle, J.V., Franklyn, J.A., Cross, K.W., Jones, S.C., Sheppard, M.C.L., Prevalence and follow up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom (1991) Clin Endocrinol (Oxf)., 34, pp. 77-83Vanderpump, M.P., Tunbridge, W.M., French, J.M., Appleton, D., Bates, D., Clark, F., The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickman Survey (1995) Clin Endocrinol (Oxf)., 43, pp. 55-68Sichieri, R., Baima, J., Marante, T., de Vasconcellos, M.T., Moura, A.S., Vaisman, M., Low prevalence of hypothyroidism among black and Mulatto people in a population-based study of Brazilian women (2007) Clin Endocrinol (Oxf)., 66, pp. 803-807Camargo, R.Y., Tomimori, E.K., Neves, S.C., Rubio, I.G., Galrão, A.L., Knobel, M., Thyroid and the environment: Exposure to excessive nutritional iodine increases the prevalence of thyroid disorders in Sao Paulo, Brazil (2008) Eur J Endocrinol., 159, pp. 293-299Sgarbi, J.A., Matsumura, L.K., Kasamatsu, T.S., Ferreira, S.R., McIel, R.M., Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: The Japanese-Brazilian thyroid study (2010) Eur J Endocrinol., 162, pp. 569-577Benseñor, I.M., Goulart, A.C., Lotufo, P.A., Menezes, P.R., Scazufca, M., Prevalence of thyroid disorders among older people: Results from the São Paulo Ageing & Health Study (2011) Cad Saude Publica., 27, pp. 155-161Walsh, J.P., Bremner, A.P., Bulsara, M.K., O'Leary, P., Leedman, P.J., Feddema, P., Subclinical thyroid dysfunction as a risk factor for cardiovascular disease (2005) Arch Intern Med., 165, p. 2467Cappola, A.R., Fried, L.P., Arnold, A.M., Danese, M.D., Kuller, L.H., Burke, G.L., Thyroid status, cardiovascular risk, and mortality in older adults (2006) JAMA., 295, pp. 1033-1041Iervasi, G., Molinaro, S., Landi, P., Taddei, M.C., Galli, E., Mariani, F., Association between increased mortality and mild thyroid dysfunction in cardiac patients (2007) Arch Intern Med., 167, pp. 1526-1532Asvold, B.O., Bjoro, T., Nilsen, T.I., Gunnell, D., Vatten, L.J., Thyrotropin levels and risk of fatal coronary heart disease: The HUNT study (2008) Arch Intern Med., 168, pp. 855-860Boekholdt, S.M., Titan, S.M., Wiersinga, W.M., Chatterjee, K., Basart, D.C., Luben, R., Initial thyroid status and cardiovascular risk factors: The EPIC-Norfolk prospective population study (2010) Clin Endocrinol (Oxf)., 72, pp. 404-410McQuade, C., Skugor, M., Brennan, D.M., Hoar, B., Stevenson, C., Hoogwerf, B.J., Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: A PreCIS database study (2011) Thyroid., 21, pp. 837-843Asvold, B.O., Bjøro, T., Platou, C., Vatten, L.J., Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT Study in Norway (2012) Clin Endocrinol (Oxf)., 77, pp. 911-917Biondi, B., Cooper, D.S., The clinical significance of subclinical thyroid dysfunction (2008) Endocr Rev., 29, pp. 76-131Rodondi, N., Aujesky, D., Vittinghoff, E., Cornuz, J., Bauer, D.C., Subclinical hypothyroidism and the risk of coronary heart disease: A meta-analysis (2006) Am J Med., 119, pp. 541-551Volzke, H., Schwahn, C., Wallaschofski, H., Dorr, M., Review: The association of thyroid dysfunction with all-cause and circulatory mortality: Is there a causal relationship? (2007) J Clin Endocrinol Metab., 92, pp. 2421-2429Razvi, S., Weaver, J.U., Vanderpump, M.P., Pearce, S.H., The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: Reanalysis of the Whickham Survey cohort (2010) J Clin Endocrinol Metab., 95, pp. 1734-1740Singh, S., Duggal, J., Molnar, J., Maldonado, F., Barsano, C.P., Arora, R., Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: A meta-analysis (2008) Int J Cardiol., 125, pp. 41-48Ochs, N., Auer, R., Bauer, D.C., Nanchen, D., Gussekloo, J., Cornuz, J., Meta-analysis: Subclinical thyroid dysfunction and the risk for coronary heart disease and mortality (2008) Ann Intern Med., 148, pp. 832-845Cooper, D.S., Halpern, R., Wood, L.C., Levin, A.A., Ridgway, E.C., L-thyroxine therapy in subclinical hypothyroidism. A doubleblind, placebo-controlled trial (1984) Ann Intern Med., 101, pp. 18-24Nystrom, E., Caidahl, K., Fager, G., Wikkelso, C., Lundberg, P.A., Lindstedt, G.A., Double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism (1988) Clin Endocrinol (Oxf)., 29, pp. 63-67Jaeschke, R., Guyatt, G., Gerstein, H., Patterson, C., Molloy, W., Cook, D., Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? (1996) J Gen Intern Med., 11, pp. 744-749Bono, G., Fancellu, R., Blandini, F., Santoro, G., Mauri, M., Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment (2004) Acta Neurol Scand., 110, pp. 59-66Volpato, S., Guralnik, J.M., Fried, L.P., Remaley, A.T., Cappola, A.R., Launer, L.J., Serum thyroxine level and cognitive decline in euthyroid older women (2002) Neurology., 58, pp. 1055-1061Kong, W.M., Sheikh, M.H., Lumb, P.J., Naoumova, R.P., Freedman, D.B., Crook, M., A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism (2002) Am J Med., 112, pp. 348-354Jorde, R., Waterloo, K., Storhaug, H., Nyrnes, A., Sundsfjord, J., Jenssen, T.G., Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment (2006) J Clin Endocrinol Metab., 91, pp. 145-153Parle, J., Roberts, L., Wilson, S., Pattison, H., Roalfe, A., Haque, M.S., A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: The Birmingham Elderly Thyroid study (2010) J Clin Endocrinol Metab., 95, pp. 3623-3632Rodondi, N., den Elzen, W.P., Bauer, D.C., Cappola, A.R., Razvi, S., Walsh, J.P., Subclinical hypothyroidism and the risk of coronary heart disease and mortality. Thyroid Studies Collaboration (2010) JAMA., 304, pp. 1365-1374Meier, C., Staub, J.J., Roth, C.B., Guglielmetti, M., Kunz, M., Miserez, A.R., TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: A double blind, placebo-controlled trial (Basel Thyroid Study) (2001) J Clin Endocrinol Metab., 86, pp. 4860-4866Caraccio, N., Ferranini, E., Monzani, F., Lipoprotein profile in subclinical hypothyroidism: Response to levothyroxine replacement, a randomized placebo-controlled study (2002) J Clin Endocrinol Metab., 87, pp. 1533-1538Monzani, F., Caraccio, N., Kozàkowà, M., Dardano, A., Vittone, F., Virdis, A., Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: A double-blind, placebo-controlled study (2004) J Clin Endocrinol Metab., 89, pp. 2099-2106Adrees, M., Gibney, J., El-Saeity, N., Boran, G., Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism (2009) Clin Endocrinol (Oxf)., 71, pp. 298-303Teixeira, P.F., Reuters, V.S., Ferreira, M.M., Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebocontrolled double-blind clinical trial (2008) Horm Metab Res., 40, pp. 50-55Biondi, B., Fazio, S., Palmieri, E.A., Carella, C., Panza, N., Cittadini, A., Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism (1999) J Clin Endocrinol Metab., 84, pp. 2064-2067Brenta, G., Mutti, L.A., Schnitman, M., Fretes, O., Perrone, A., Matute, M.L., Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy (2003) Am J Cardiol., 91, pp. 1327-1330Arem, R., Rokey, R., Kiefe, C., Escalante, D.A., Rodriguez, A., Cardiac systolic and diastolic function at rest and exercise in subclinical hypothyroidism: Effect of thyroid hormone therapy (1996) Thyroid., 6, pp. 397-402Franzoni, F., Galetta, F., Fallahi, P., Tocchini, L., Merico, G., Braccini, L., Effect of L-thyroxine treatment on left ventricular function in subclinical hypothyroidism (2006) Biomed Pharmacother., 60, pp. 431-436Razvi, S., Weaver, J.U., Butler, T.J., Pearce, S.H., Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality (2012) Arch Intern Med., 172 (10), pp. 811-817Garber, J.R., Cobin, R.H., Gharib, H., Hennessey, J.V., Klein, I., Mechanick, J.I., Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association (2012) Thyroid., 22, pp. 1200-1235. , American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in AdultsSimonsick, E.M., Newman, A.B., Ferrucci, L., Satterfield, S., Harris, T.B., Rodondi, N., Subclinical hypothyroidism and functional mobility in older adults (2009) Arch Intern Med., 169, pp. 2011-2017. , for the Health ABC StudyVaisman, F., Coeli, C.M., Ward, L.S., Graf, H., Carvalho, G., Montenegro Jr., R., How good is the levothyroxine replacement in primary hypothyroidism patients in Brazil?-Data of a multicentre study (2013) J Endocrinol Invest, , Jan 14. [Epub ahead of print] PMID:23324400Collet, T.H., Gussekloo, J., Bauer, D.C., den Elzen, W.P., Cappola, A.R., Balmer, P., Thyroid Studies Collaboration. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality (2012) Arch Intern Med., 172, pp. 799-809Sawin, C.T., Geller, A., Wolf, P.A., Belanger, A.J., Baker, E., Bacharach, P., Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons (1994) N Engl J Med., 331, pp. 1249-1252Faber, J., Galløe, A.M., Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: A metaanalysis (1994) Eur J Endocrinol., 130, pp. 350-356Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., American Thyroid Association Task Force on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum (2011) Thyroid., 21, pp. 1081-1125Stricker, R., Echenard, M., Eberhart, R., Chevailler, M.C., Perez, V., Quinn, F.A., Evaluation of maternal thyroid function during pregnancy: The importance of using gestational age-specific reference intervals (2007) Eur J Endocrinol., 157, pp. 509-514Lee, R.H., Spencer, C.A., Mestman, J.H., Miller, E.A., Petrovic, I., Braverman, L.E., Free T4 immunoassays are flawed during pregnancy (2009) Am J Obstet Gynecol., 200, pp. 260.e1-260.e6Vieira, J.G.H., Kanashiro, I., Tachibana, T.T., Ghiringhello, M.T., Hauache, O.M., McIel, R.M.B., Definição de valores normais de tiroxina livre durante a gravidez (2004) Arq Bras Endocrinol Metab., 48, pp. 305-309Benhadi, N., Wiersinga, W.M., Reitsma, J.B., Vrijkotte, T.G., Bonsel, G.J., Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death (2009) Eur J Endocrinol., 160, pp. 985-991Levels of Evidence and Grades of Recommendations-Oxford Centre for Evidence-Based Medicine, , http://www.cebm.net/index.aspx?o=1025, Disponível em URLNegro, R., Schwartz, A., Gismondi, R., Tinelli, A., Mangieri, T., Stagnaro-Green, A., Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes (2011) J Clin Endocrinol Metab., 96, pp. E920-E924Allan, W.C., Haddow, J.E., Palomaki, G.E., Williams, J.R., Mitchell, M.L., Hermos, R.J., Maternal thyroid deficiency and pregnancy complications: Implications for population screening (2000) J Med Screen., 7, pp. 127-130Casey, B.M., Dashe, J.S., Wells, C.E., McIntire, D.D., Leveno, K.J., Cunningham, F.G., Subclinical hyperthyroidism and pregnancy outcomes (2006) Obstet Gynecol., 107, pp. 337-341Cleary-Goldman, J., Malone, F.D., Lambert-Messerlian, G., Sullivan, L., Canick, J., Porter, T.F., Maternal thyroid hypofunction and pregnancy outcome (2008) Obstet Gynecol., 112, pp. 85-92Lavado-Autric, R., Ausó, E., García-Velasco, J.V., Arufe Mdel, C., del Escobar Rey, F., Berbel, P., Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny (2003) J Clin Invest., 111, pp. 1073-1082Pop, V.J., Kuijpens, J.L., van Baar, A.L., Verkerk, G., van Son, M.M., de Vijlder, J.J., Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy (1999) Clin Endocrinol (OxfPrograma Diretrizes, , http://www.projetodiretrizes.amb.org.br, Associação Médica Brasileira. Disponível em URLBaloch, Z., Carayon, P., Conte-Devolx, B., Demers, L.M., Feldt-Rasmussen, U., Henry, J.F., Laboratory Medicine Practice Guidelines: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease (2003) Thyroid., 13, pp. 57-67Kratzsch, J., Fiedler, G.M., Leichtle, A., Brügel, M., Buchbinder, S., Otto, L., New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid (2005) Clin Chem., 51, pp. 1480-1486Boucai, L., Hollowell, J.G., Surks, M.I., An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits (2011) Thyroid., 21, pp. 5-11Rosario, P.W., Xavier, A.C., Calsolari, M.R., TSH reference values for adult Brazilian population (2010) Arq Bras Endocrinol Metab., 54, pp. 603-606Razvi, S., Shakoor, A., Vanderpump, M., Weaver, J.U., Pearce, S.H., The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: A metaanalysis (2008) J Clin Endocrinol Metab., 93, pp. 2998-3007Atzmon, G., Barzilai, N., Hollowell, J.G., Surks, M.I., Gabriely, I., Extreme longevity is associated with increased serum thyrotropin (2009) J Clin Endocrinol Metab., 94, pp. 1251-1254Verburg, F.A., Kirchgässner, C., Hebestreit, H., Steigerwald, U., Lentjes, E.G., Ergezinger, K., Reference ranges for analyses of thyroid function in children (2011) Horm Metab Res., 43, pp. 422-426Kapelari, K., Kirchlechner, C., Högler, W., Schweitzer, K., Virgolini, I., Moncayo, R., Pediatric reference intervals for thyroid hormone levels from birth to adulthood: A retrospective study (2008) BMC Endocr Disord., 27, pp. 8-15Soldin, O.P., Soldin, D., Sastoque, M., Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide (2007) Ther Drug Monit., 29, pp. 553-559Balthazar, U., Steiner, A.Z., Periconceptional changes in thyroid function: A longitudinal study (2012) Reprod Biol Endocrinol., 10, p. 20. , doi: 10.1186/1477-7827-10-20.XXHaddow, J.E., Knight, G.J., Palomaki, G.E., McClain, M.R., Pulkkinen, A.J., The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy (2004) J Med Screen., 11 (4), pp. 170-174Bocos-Terraz, J.P., Izquierdo-Alvarez, S., Bancalero-Flores, J.L., Alvarez-Lahuerta, R., Aznar-Sauca, A., Real-López, E., Thyroid hormones according to gestational age in pregnant Spanish women (2009) BMC Res Notes., 2, p. 237Surks, M.I., Hollowell, J.G., Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: Implications for the prevalence of subclinical hypothyroidism (2007) J Clin Endocrinol Metab., 92, pp. 4575-4582Ladenson, P.W., Braverman, L.E., Mazzaferri, E.L., Brucker-Davis, F., Cooper, D.S., Garber, J.R., Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma (1997) N Engl J Med., 337, pp. 888-896Ismail, A.A., Burr, W.A., Walker, P.L., Acute changes in serum thyrotrophin in treated Addison's disease (1989) Clin Endocrinol (Oxf)., 30, pp. 225-230Ward, G., McKinnon, L., Badrick, T., Hickman, P.E., Heterophilic antibodies remain a problem for the immunoassay laboratory (1997) Am J Clin Pathol., 108, pp. 417-421Jordan, N., Williams, N., Gregory, J.W., Evans, C., Owen, M., Ludgate, M., The W546X mutation of the thyrotropin receptor gene: Potential major contributor to thyroid dysfunction in a Caucasian population (2003) J Clin Endocrinol Metab., 88, pp. 1002-1005Fatourechi, V., Aniszewski, J.P., Fatourechi, G.Z., Atkinson, E.J., Jacobsen, S.J., Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study (2003) J Clin Endocrinol Metab., 88, pp. 2100-2105Peden, N.R., Hart, I.R., The early development of transient and permanent hypothyroidism following radioiodine therapy for hyperthyroid Graves' disease (1984) Can Med Assoc J., 130, pp. 1141-1144Bhakri, H.L., Fisher, R., Khadri, A., McMahon, D.G., Longitudinal study of thyroid function in acutely ill elderly patients using a sensitive TSH assay-defer testing until recovery (1990) Gerontology., 36, pp. 140-144Meyerovitch, J., Rotman-Pikielny, P., Sherf, M., Battat, E., Levy, Y., Surks, M.I., Serum thyrotropin measurements in the community: Fiveyear follow-up in a large network of primary care physicians (2007) Arch Intern Med., 167, pp. 1533-1538Díez, J.J., Iglesias, P., Burman, K.D., Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism (2005) J Clin Endocrinol Metab., 90, pp. 4124-4127Diez, J.J., Iglesias, P., Spontaneous subclinical hypothyroidism in patients older than 55 years: An analysis of natural course and risk factors for the development of overt thyroid failure (2004) J Clin Endocrinol Metab., 89, pp. 4890-4897Karmisholt, J., Andersen, S., Laurberg, P.A., Variation in thyroid function in subclinical hypothyroidism: Importance of clinical follow-up and therapy (2011) Eur J Endocrinol., 164, pp. 317-323Walsh, J.P., Bremner, A.P., Feddema, P., Leedman, P.J., Brown, S.J., O'Leary, P., Thyrotropin and thyroid antibodies as predictors of hypothyroidism: A 13-year, longitudinal study of a communitybased cohort using current immunoassay techniques (2010) J Clin Endocrinol Metab., 95, pp. 1095-1104Huber, G., Staub, J.J., Meier, C., Mitrache, C., Guglielmetti, M., Huber, P., Prospective study of the spontaneous course of subclinical hypothyroidism: Prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies (2002) J Clin Endocrinol Metab., 87, pp. 3221-3226Rosario, P.W., Bessa, B., Valadao, M.M., Purisch, S., Natural history of mild subclinical hypothyroidism: Prognostic value of ultrasound (2009) Thyroid., 19, pp. 9-12Marcocci, C., Vitti, P., Cetani, F., Catalano, F., Concetti, R., Pinchera, A., Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism (1991) J Clin Endocrinol Metab., 72, pp. 209-213Li, Y., Teng, D., Shan, Z., Teng, X., Guan, H., Yu, X., Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes (2008) J Clin Endocrinol M

Normal flow-mediated vasodilatation of the brachial artery and carotid artery intima-media thickness in subclinical hypothyroidism

Subclinical hypothyroidism (SHT) is a disease for which exact therapeutic approaches have not yet been established. Previous studies have suggested an association between SHT and coronary heart disease. Whether this association is related to SHT-induced changes in serum lipid levels or to endothelial dysfunction is unclear. The aim of this study was to determine endothelial function measured by the flow-mediated vasodilatation of the brachial artery and the carotid artery intima-media thickness (IMT) in a group of women with SHT compared with euthyroid subjects. Triglycerides, total cholesterol, HDL-C, LDL-C, apoprotein A (apo A), apo B, and lipoprotein(a) were also determined. Twenty-one patients with SHT (mean age: 42.4 ± 10.8 years and mean thyroid-stimulating hormone (TSH) levels: 8.2 ± 2.7 µIU/mL) and 21 euthyroid controls matched for body mass index, age and atherosclerotic risk factors (mean age: 44.2 ± 8.5 years and mean TSH levels: 1.4 ± 0.6 µIU/mL) participated in the study. Lipid parameters (except HDL-C and apo A, which were lower) and IMT values were higher in the common carotid and carotid bifurcation of SHT patients with positive serum thyroid peroxidase antibodies (TPO-Ab) (0.62 ± 0.2 and 0.62 ± 0.16 mm for the common carotid and carotid bifurcation, respectively) when compared with the negative TPO-Ab group (0.55 ± 0.24 and 0.58 ± 0.13 mm, for common carotid and carotid bifurcation, respectively). The difference was not statistically significant. We conclude that minimal thyroid dysfunction had no adverse effects on endothelial function in the population studied. Further investigation is warranted to assess whether subclinical hypothyroidism, with and without TPO-Ab-positive serology, has any effect on endothelial function

Brazilian Flora 2020: Leveraging the power of a collaborative scientific network

International audienceThe shortage of reliable primary taxonomic data limits the description of biological taxa and the understanding of biodiversity patterns and processes, complicating biogeographical, ecological, and evolutionary studies. This deficit creates a significant taxonomic impediment to biodiversity research and conservation planning. The taxonomic impediment and the biodiversity crisis are widely recognized, highlighting the urgent need for reliable taxonomic data. Over the past decade, numerous countries worldwide have devoted considerable effort to Target 1 of the Global Strategy for Plant Conservation (GSPC), which called for the preparation of a working list of all known plant species by 2010 and an online world Flora by 2020. Brazil is a megadiverse country, home to more of the world's known plant species than any other country. Despite that, Flora Brasiliensis, concluded in 1906, was the last comprehensive treatment of the Brazilian flora. The lack of accurate estimates of the number of species of algae, fungi, and plants occurring in Brazil contributes to the prevailing taxonomic impediment and delays progress towards the GSPC targets. Over the past 12 years, a legion of taxonomists motivated to meet Target 1 of the GSPC, worked together to gather and integrate knowledge on the algal, plant, and fungal diversity of Brazil. Overall, a team of about 980 taxonomists joined efforts in a highly collaborative project that used cybertaxonomy to prepare an updated Flora of Brazil, showing the power of scientific collaboration to reach ambitious goals. This paper presents an overview of the Brazilian Flora 2020 and provides taxonomic and spatial updates on the algae, fungi, and plants found in one of the world's most biodiverse countries. We further identify collection gaps and summarize future goals that extend beyond 2020. Our results show that Brazil is home to 46,975 native species of algae, fungi, and plants, of which 19,669 are endemic to the country. The data compiled to date suggests that the Atlantic Rainforest might be the most diverse Brazilian domain for all plant groups except gymnosperms, which are most diverse in the Amazon. However, scientific knowledge of Brazilian diversity is still unequally distributed, with the Atlantic Rainforest and the Cerrado being the most intensively sampled and studied biomes in the country. In times of “scientific reductionism”, with botanical and mycological sciences suffering pervasive depreciation in recent decades, the first online Flora of Brazil 2020 significantly enhanced the quality and quantity of taxonomic data available for algae, fungi, and plants from Brazil. This project also made all the information freely available online, providing a firm foundation for future research and for the management, conservation, and sustainable use of the Brazilian funga and flora